RADIatE Shows How Prospective Registries Can Strengthen Radiation Oncology Research
The E2-RADIatE project, a collaborative effort between EORTC and ESTRO, is utilizing prospective registries to gather real-world data on radiotherapy outcomes. This initiative aims to bridge the evidence gap in radiation oncology, where randomized trials are often difficult to execute.
Why it matters
Improving data collection in radiation oncology allows for faster innovation and better evidence-based treatment protocols for cancer patients.
Radiotherapy is a cornerstone of cancer care, but radiation oncology research still represents only a small part of the global oncology research portfolio.
A new article published in Radiotherapy and Oncology highlights how prospective registries and real-world data can help close this evidence gap.
The paper reports five years of experience from E2-RADIatE, the EORTC-ESTRO Radiotherapy Infrastructure for Europe, a collaborative project launched in 2019 by the European Organisation for Research and Treatment of Cancer and the European Society for Radiotherapy and Oncology.
The platform was created to collect prospective real-world data on cancer patients, radiotherapy treatments, and outcomes across Europe.
Radiotherapy continues to evolve rapidly.
New technologies, treatment techniques, clinical indications, combinations with systemic therapies, and workflow innovations are constantly entering practice.
However, generating evidence for radiotherapy innovations is often difficult.
Get smarter about the news
Sign up free for a feed built around what you actually care about, Dive Deeper research on any story, and the full text of every article.
Create free accountAlready have an account? Sign in